Log in to save to my catalogue

To what degree are orphan drugs patient-centered? A review of the current state of clinical research...

To what degree are orphan drugs patient-centered? A review of the current state of clinical research...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5394831c56394917872056e30082bb33

To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases

About this item

Full title

To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases

Publisher

London: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2020-06, Vol.15 (1), p.1-134, Article 134

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Over the past 30 years, the healthcare industry has increasingly turned its attention to rare diseases. Regulators have emphasized the need for clinical research in this area to be patient-centered. However, there is a lack of evidence concerning whether this need is actually met. In this paper, we aim to address this gap. First, we describe the st...

Alternative Titles

Full title

To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5394831c56394917872056e30082bb33

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5394831c56394917872056e30082bb33

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-020-01400-0

How to access this item